Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma
about
Survivin expression and its clinical significance in pancreatic cancer.Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model systemSurvivin: A molecular biomarker in cancerThe role of survivin in podocyte injury induced by puromycin aminonucleosideModified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model.Differential c-erbB-1 and c-erbB-2 mRNA expression in cancer of the pancreas compared with cancer of the papilla of Vater.Enhancement of cisplatin sensitivity in Lewis Lung carcinoma by liposome-mediated delivery of a survivin mutant.Biological approaches to therapy of pancreatic cancer.Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinomaImpacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivinSurvivin and pancreatic cancer.MMI-166, a selective matrix metalloproteinase inhibitor, promotes apoptosis in human pancreatic cancer.Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.Promoters with cancer cell-specific activity for melanoma gene therapy.Expression of Survivin in pancreatic cancer and its correlation to expression of Bcl-2.Expression of survivin protein in human colorectal carcinogenesis.Expression of a novel apoptosis inhibitor-survivin in colorectal carcinoma.Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenovirusesSurvivin expression induced by doxorubicin in cholangiocarcinoma.Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients.High expression of survivin is prognostic of shorter survival but not predictive of adjuvant gemcitabine benefit in patients with resected pancreatic adenocarcinoma.Apoptotic pathways in pancreatic ductal adenocarcinomaEfficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.Vaccinia virus, a promising new therapeutic agent for pancreatic cancer.DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters.Enhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer.Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant.Molecular changes in pancreatic cancer.Sequence-dependent combination therapy with doxorubicin and a survivin-specific small interfering RNA nanodrug demonstrates efficacy in models of adenocarcinoma.Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors.Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer.Survivin in solid tumors: rationale for development of inhibitors.Monitoring survivin expression in cancer: implications for prognosis and therapy.Molecular beacon imaging of tumor marker gene expression in pancreatic cancer cells.Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation.Anticancer Effect and Apoptosis Induction of Gambogic Acid in Human Leukemia Cell Line K562 In Vitro.Arctigenin enhances chemosensitivity to cisplatin in human nonsmall lung cancer H460 cells through downregulation of survivin expression.ncRuPAR inhibits gastric cancer progression by down-regulating protease-activated receptor-1.
P2860
Q24815846-6E7D0018-65E0-4E41-8449-4527D7D2485CQ25257352-C1F579B1-17F4-421E-9A3E-FC4EDEF4D5AEQ26823439-656433B6-05F8-49D4-BCFF-E1FD957331C5Q33580748-3BE8D9BB-FAC7-45C4-A560-15BA701DBC6AQ33723063-DDD482E1-84F7-4938-8BFA-981094E04749Q33788222-77EDBBB9-19FC-40D5-AD05-46868613B1C6Q33884322-B56B43BA-D278-4672-9AF1-2473FA510A6EQ33899938-19FB39DD-BDFA-4A36-BFDE-172B23E5511DQ34225286-B598C5D3-5B0B-4C42-8AA0-D28FFDACC739Q34871780-A616CFF1-0E37-4F9B-88AF-10F4087EA9B3Q35000802-58D28A6E-3509-4464-82EB-7FB6B7DA593BQ35486454-D816D92F-679F-4D40-A201-373748D08086Q35588363-322170AC-ACAD-4DF1-8D30-F8257AA48404Q35944371-903250FE-A15C-4A08-A1BF-60F29FD95B38Q36065831-DAB611FB-CEDE-4C16-8281-D3181C5E476DQ36178566-FED9D29C-A474-464D-B7A2-892C453D1D86Q36190356-20DAF044-2451-40DF-AA5E-3F2E9D37E12EQ36387918-CCD5346C-4B7E-4FC3-8B20-CEEB938B3160Q36496229-EBD4063F-FB8A-4724-AF3D-E88036316E6CQ36615708-FFA2A692-7B22-422D-B400-8FC2F4872ECCQ36616034-4C0ACBA1-B0BB-47DB-B76A-68BC053FC3A0Q36796262-D24EB55E-5612-4D2A-8FCB-B1D09ACAFD9FQ36835642-A4868636-0CC6-4476-942F-A4562D27438BQ36942524-5DF653FA-4EAF-46D6-B6F7-0D85E6190512Q37158473-EF9172AD-9560-4A41-A146-176932ABD079Q37335202-DBE499AF-55DB-421D-B3AF-9D2DA41572ADQ37440160-EAA923CA-5205-4367-BB0C-064EA143EC39Q37593002-8C5C38CD-6298-47F5-88D7-BBCA19DFBF88Q37614592-503A19B3-090A-4573-905E-D7F5D1C09AB5Q37625849-C5B5C9FE-DC60-46A2-9305-CE81C82B6A88Q37714442-C627345C-3487-4EC5-A14D-F04D22AFBE0EQ37859255-B2C3F022-6C1D-44AF-9DEF-D37A9D0150E6Q37885319-0BC32BE1-127A-410C-92CE-770B8A2987DBQ37974867-851B6F6F-E25D-4416-B20F-8455E06A708DQ38126394-84936E65-0D97-4715-8AEF-C21F75444B54Q38267628-9EFC5792-704F-46C7-A501-1C754E7613BEQ38446852-4ED15EF1-17F8-439F-B3D0-5591EAB46948Q38866753-9117BBAA-E47E-40D0-967B-C7AF4D39F0D0Q39036970-156B05EB-3329-4DF1-A014-1FEC1BE83E99Q39194587-5DE33588-7516-46E7-BFEA-30DC2598FA04
P2860
Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Expression of survivin, a nove ...... , in pancreatic adenocarcinoma
@ast
Expression of survivin, a nove ...... , in pancreatic adenocarcinoma
@en
type
label
Expression of survivin, a nove ...... , in pancreatic adenocarcinoma
@ast
Expression of survivin, a nove ...... , in pancreatic adenocarcinoma
@en
prefLabel
Expression of survivin, a nove ...... , in pancreatic adenocarcinoma
@ast
Expression of survivin, a nove ...... , in pancreatic adenocarcinoma
@en
P2093
P2860
P356
P1476
Expression of survivin, a nove ...... , in pancreatic adenocarcinoma
@en
P2093
A F Markham
A I Sarela
C L Davies
C S Verbeke
J Ramsdale
P J Guillou
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600133
P407
P577
2002-03-01T00:00:00Z